enVVeno Medical Corporation

DB:5HJ Stock Report

Market Cap: €56.9m

enVVeno Medical Management

Management criteria checks 3/4

enVVeno Medical's CEO is Robert Berman, appointed in Apr 2018, has a tenure of 7.08 years. total yearly compensation is $1.16M, comprised of 43.1% salary and 56.9% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth €72.19K. The average tenure of the management team and the board of directors is 6 years and 6.6 years respectively.

Key information

Robert Berman

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage43.06%
CEO tenure7.1yrs
CEO ownership0.1%
Management average tenure6yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Robert Berman's remuneration changed compared to enVVeno Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$21m

Dec 31 2024US$1mUS$500k

-US$22m

Sep 30 2024n/an/a

-US$21m

Jun 30 2024n/an/a

-US$21m

Mar 31 2024n/an/a

-US$22m

Dec 31 2023US$2mUS$500k

-US$24m

Sep 30 2023n/an/a

-US$24m

Jun 30 2023n/an/a

-US$25m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$466kUS$450k

-US$25m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$24m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$10mUS$400k

-US$17m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$1mUS$400k

-US$10m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$7m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$415kUS$400k

-US$8m

Sep 30 2019n/an/a

-US$7m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$13m

Dec 31 2018US$906kUS$293k

-US$16m

Compensation vs Market: Robert's total compensation ($USD1.16M) is above average for companies of similar size in the German market ($USD492.89K).

Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.

CEO

Robert Berman (61 yo)

7.1yrs

Tenure

US$1,161,132

Compensation

Mr. Robert A. Berman serves as Chief Executive Officer and Director of enVVeno Medical Corporation (formerly known as Hancock Jaffe Laboratories, Inc.) since April 2018. From September 2017 to March 2018,...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Berman
CEO & Director7.1yrsUS$1.16m0.13%
€ 72.2k
Craig Glynn
CFO, Treasurer & Secretary5.1yrsUS$302.23k0%
€ 0
Hamed Alavi
Senior VP & Chief Technology Officer2.3yrsUS$521.90k0%
€ 0
Marc Glickman
Senior VP & Chief Medical Officer9yrsUS$626.57k0.0091%
€ 5.2k
Warren Hancock
Co-founder38.3yrsno datano data
Sandy Prietto
Vice President of Marketing1.3yrsno datano data
Benedict Broennimann
Chief Medical Officer of Outside of United States7yrsUS$240.00kno data
Andrew Cormack
Chief Commercial Officer1.1yrsno datano data

6.0yrs

Average Tenure

63yo

Average Age

Experienced Management: 5HJ's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Berman
CEO & Director7.1yrsUS$1.16m0.13%
€ 72.2k
Robert Gray
Independent Director5.7yrsUS$77.50k0.059%
€ 33.6k
Matthew Jenusaitis
Independent Director5.7yrsUS$75.00k0.090%
€ 51.1k
Francis Duhay
Independent Director6.6yrsUS$70.00k0.58%
€ 332.3k
Sanjay Shrivastava
Independent Director6.6yrsUS$75.00k0.053%
€ 30.2k

6.6yrs

Average Tenure

62yo

Average Age

Experienced Board: 5HJ's board of directors are considered experienced (6.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 13:06
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

enVVeno Medical Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey CohenLadenburg Thalmann & Company